Search Virginia Mason News
Virginia Mason Recognized by U.S. News & World Report in ‘America’s Best Hospitals’ Ranking
VM Ranks in the Top 50 Hospitals Nationwide for Digestive Disorders
U.S. News & World Report announced its “America’s Best Hospitals” ranking citing Virginia Mason Medical Center as one of the Top 50 Hospitals in the nation for gastroenterological care. Listed number 28 of 50, Virginia Mason’s Digestive Disorders care is one of six hospitals from the west coast to receive such recognition.
U.S. News & World Report ranks 203 top medical centers in 17 specialties every year. The specialty rankings include Digestive Disorders, Cancer, Geriatrics, Heart and Heart Surgery, Kidney rankings and more, and represent hospital scores that assess such outcomes as mortality ratios, discharges (over three years) and key technologies that comprise outstanding care. Only 177, or fewer than 1 in 30 medical centers, were ranked in even a single specialty this year of all 6,012 U.S. medical centers.
Richard A. Kozarek, MD, section head of Virginia Mason’s Gastroenterology Services Department said, “This is exciting news for us. Patients come from all over the world to receive care from our interdisciplinary medical team for GI disorders – and we take great pride in this recognition. Pancreatic cancer, therapeutic endoscopic cholangio-pancreatography (ERCP), occult GI bleeding and inflammatory bowel disease – no matter what the disease challenge is, we’re focused on the patient.”
Adding to data recently noted by HealthGrades, a health care quality ratings organization, this U.S. News & World Report ranking confirms Virginia Mason’s overall hospital mortality rates for gastroenterologic services as some of the lowest in the country.
Offering a wide range of diagnostic and therapeutic gastroenterologic services, Virginia Mason provides expertise in such areas as photodynamic therapy for esophageal and unresectable biliary cancers, electrogastrography and gastric pacemaker placement for refractory gastroparesis, and a large variety of investigational medications and procedures for severe reflux, refactory inflammatory bowel disease, and gut motility disorders.
“This is terrific acknowledgment for a No. 1 GI team-- including physicians in a multitude of disciplines, nurses, and other support staff all working together to give each patient the highest quality care,” said Dr. Kozarek. “From the time the patient calls on the phone to the time he or she is discharged, each team member focuses on the patient—and provides highly individualized care. I am very proud to be a part of such a great team.”